Transforming melanoma treatment through next-generation RNA therapeutics.

A Sapienza University of Rome spin-off developing innovative RNA-based therapies to overcome resistance and improve patient outcomes. 

Currently in preclinical development, seeking strategic partners and early-stage investors.